Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial

PaperCitations, authors & open-access status

Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 186 citations, 2000 year and closed oa status.

186
Citations
2000
Year
closed
OA Status

Related on ScholarIQ

Angelo Bolognesi
Author
Journal of Clinical Oncology
Journal
Breast Cancer Treatment Studies
Topic
Breast Cancer Treatment Studies
Topic
Estrogen and related hormone effects
Topic
Menopause: Health Impacts and Treatments
Topic
470M+ articles · free account